4-苯酰胺-5-二丙氨基-5-氧戊酸钠盐

4-苯酰胺-5-二丙氨基-5-氧戊酸钠盐

中文名称4-苯酰胺-5-二丙氨基-5-氧戊酸钠盐
中文同义词4-苯酰胺-5-二丙氨基-5-氧戊酸钠盐;丙谷胺钠;化合物 T23185;丙谷胺 钠盐
英文名称PROGLUMIDE, SODIUM SALT
英文同义词DL-4-(BENZOYLAMINO)-5-(DIPROPYLAMINO)-5-OXOPENTANOIC ACID, NA;4-BENZOYLAMINO-5-DIPROPYLAMINO-5-OXOPENTANOIC ACID SODIUM;PROGLUMIDE SODIUM;PROGLUMIDE, SODIUM SALT;4-benzamido-n,n-dipropyl-,sodiumsalt,dl-glutaramicaci;dl-4-benzamido-n,n-dipropylglutaramicacidsodiumsalt;pentanoicacid,4-(benzoylamino)-5-(dipropylamino)-5-oxo-,monosodiumsalt,(;PROGLUMIDE SODIUM SALT SELECTIVE CHOLECY STOK
CAS号99247-33-3
分子式C18H27N2NaO4
分子量358.41
EINECS号
相关类别
Mol文件99247-33-3.mol
结构式4-苯酰胺-5-二丙氨基-5-氧戊酸钠盐 结构式

4-苯酰胺-5-二丙氨基-5-氧戊酸钠盐 性质

储存条件Desiccate at RT
溶解度可溶于水中
形态固体
颜色白色
水溶解性Soluble to 100 mM in water

4-苯酰胺-5-二丙氨基-5-氧戊酸钠盐 用途与合成方法

Proglumide sodium 是一种非肽和口服活性胆囊收缩素 (CCK)-A/B 受体拮抗剂。Proglumide sodium 选择性阻断 CCK 在中枢神经系统中的作用。Proglumide sodium 具有抑制胃分泌和保护胃十二指肠粘膜的能力,还具有抗癫痫和抗氧化活性。

Cholecystokinin (CCK)-A/B receptors

In an in vitro study, Proglumide at concentrations between 0.3-10 mM inhibits CCK-stimulated amylase release dose-dependently, while Proglumide does not influence the basal amylase release at concentrations between 0-3 mM. Dose-response curves to CCK for amylase release shifted to the right with increase in Proglumide concentration. This inhibition by Proglumide is reversible. In addition, the effect of Proglumide is selective for CCK and its related peptide.
The incubation of HT29 cells with Proglumide significantly reduces the [ 3 H]-thymidine incorporation to HT29 cells in a dose-dependent manner, with an IC 50 of 6.5 mM. Proglumide reduces in a dose-dependent manner the percentage of necrosis with a parallel increase of apoptosis up to 70%.

Proglumide (250-750 mg/kg; intraperitoneal injection; adult male Sprague Dawley rats) treatment is significantly effective in ameliorating the seizure activities, cognitive dysfunctions, and cerebral oxidative stress.

Animal Model: Adult male Sprague Dawley rats (200-250 g; 2 months old) are induced status epilepticus (SE)
Dosage: 250 mg/kg, 500 mg/kg, and 750 mg/kg
Administration: Intraperitoneal injection
Result: Dose-dependently and significantly increased the latencies to seizure and SE. Significantly and dose-dependently attenuated Li-PC (SE) induced increase in thiobarbituric acid (TBARS) and catalase (CAT), attenuated Li-Pc induced decrease in SOD, and attenuated depletion of GSH and glutathione-S transferase (GST) in the hippocampus and striatum.

安全信息

WGK Germany3

MSDS信息

提供商 语言
英文
更新日期产品编号产品名称CAS号包装价格
2024/01/25HY-1033544-苯酰胺-5-二丙氨基-5-氧戊酸钠盐
Proglumide sodium
99247-33-350mg600元
2024/01/25HY-1033544-苯酰胺-5-二丙氨基-5-氧戊酸钠盐
Proglumide sodium
99247-33-310mM * 1mLin Water660元

4-苯酰胺-5-二丙氨基-5-氧戊酸钠盐 上下游产品信息

"4-苯酰胺-5-二丙氨基-5-氧戊酸钠盐"相关产品信息
烷基酰胺 对乙酰胺基苯磺酰氯 2-乙氧基苯甲酰胺 二丙谷酰胺 氯戊米特
主页 | 企业会员服务 | 广告业务 | 联系我们 | 旧版入口 | 中文MSDS | CAS Index | 常用化学品CAS列表 | 化工产品目录 | 新产品列表 | 评选活动 | HS海关编码 | MSDS查询 | 化工站点

Copyright © 2016-2023 ChemicalBook 版权所有  京ICP备07040585号  京公海网安备11010802032676号  

互联网增值电信业务经营许可证:京ICP证150597号  互联网药品信息服务资格证编号(京)-非经营性-2015-0073  信息系统安全等级保护备案证明(三级)  营业执照公示

根据相关法律法规和本站规定,单位或个人购买相关危险物品应取得有效的资质、资格条件。
参考《应急管理部等多部门关于加强互联网销售危险化学品安全管理的通知 (应急〔2022〕119号)》《互联网危险物品信息发布管理规定》